NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by β-amyloid protein in rats

European Journal of Pharmacology

Volumn 352, Issue 2-3, 1998, Pages 135-142

  Tanaka, Tomoko ^a,b   Yamada, Kiyofumi ^a   Senzaki, Kouji ^a   Narimatsu, Hiroto ^a   Nishimura, Kyoko ^a   Kameyama, Tsutomu ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

amyloid protein; Alzheimer's disease; Arginine vasopressin; Choline acetyltransferase; Learning; Memory; NC 1900

Indexed keywords

AMYLOID BETA PROTEIN; ARGIPRESSIN DERIVATIVE; CHOLINE ACETYLTRANSFERASE; NC 1900; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; LEARNING; LEARNING DISORDER; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMYLOID BETA-PROTEIN; ANIMALS; ARGININE VASOPRESSIN; BEHAVIOR, ANIMAL; CHOLINE O-ACETYLTRANSFERASE; FRONTAL LOBE; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LEARNING DISORDERS; MALE; MEMORY DISORDERS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, WISTAR;

EID: 0031879794     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00344-6     Document Type: Article

References (37)

1. Alescio-Lautier, B., Devigne, C., Soumireu-Mourat, B., 1987. Hippocampal lesions block behavioral effects of central but not of peripheral pre-test injection of arginine vasopressin in an appetitive learning task. Behav. Brain Res. 26, 159-169.
2. Bohus, B., Ader, R., De Wied, D., 1972. Effects of vasopressin on active and passive avoidance behavior. Horm. Behav. 3, 191-197.
3. Burbach, J.P., Kovacs, G.L., De Wied, D., Van Nispen, J.W., Greven, H.M., 1983. A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide. Science 221, 1310-1312.
4. Coyle, J.T., Price, D.L., Delong, M.R., 1983. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1190.
5. De Wied, D., Versteeg, D.H., 1979. Neurohypophyseal principles and memory. Fed. Proc. 38, 2348-2354.
6. De Wied, D., Gaffori, O., Van Ree, J.M., De Jong, W., 1984. Central target for the behavioral effects of vasopressin neuropeptides. Nature 308, 276-278.
7. De Wied, D., Gaffori, O., Burbach, J.P., Kovacs, G.L., Van Ree, J.M., 1987. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J. Pharmacol. Exp. Ther. 241, 268-274.
8. Dietrich, A., Allen, J.D., 1997. Vasopressin and memory: II. Lesion to the hippocampus block the memory enhancing effects of AVP(4-9) in the radial maze. Behav. Brain Res. 87, 201-208.
9. Fujiwara, M., Ohgaki, Y., Inada, K., Iwasaki, K., 1997. Effect of active fragments of arginine vasopressin on the disturbance of spatial cognition in rats. Behav. Brain Res. 83, 91-96.
10. 6] AVP(4-9) analogue, prevents the disruption of avoidance behavior. Behav. Brain Res. 83, 205-208.
11. Itoh, A., Nitta, A., Nadai, M., Nishimura, K., Hirose, M., Hasegawa, T., Nabeshima, T., 1996. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66, 1113-1117.
12. Kaneda, N., Nagatsu, T., 1985. Highly sensitive assay for choline acetyltransferase activity by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 341, 23-30.
13. Maegawa, H., Katsube, N., Okegawa, T., Aishita, H., Kawasaki, A., 1992. Arginine vasopressin fragment 4-9 stimulates the acetylcholine release in hippocampus of freely moving rats. Life Sci. 51, 285-293.
14. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Beyreuther, K., 1985. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
15. Maurice, T., Hiramatsu, M., Itoh, J., Kameyama, T., Hasegawa, T., Nabeshima, T., 1994. Behavioral evidence for a modulating role of σ ligands in memory processes: I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647, 44-56.
16. Miyagawa, H., Hasegawa, M., Fukuta, T., Amano, M., Yamada, K., Nabeshima, T., 1998. Dissociation of impairment between spatial memory and motor function and emotional behavior in aged rats. Behav. Brain Res., in press.
17. Morris, R.G.M., 1984. Developments of water maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
18. Müller-Hill, B., Beyreuther, K., 1989. Molecular biology of Alzheimer's disease. Annu. Rev. Biochem. 58, 287-307.
19. Nabeshima, T., Itoh, A., 1996. Toxicity of β-amyloid protein: neurochemical, histological and behavioral changes. In: Iqbal, K. et al. (Eds.), Alzheimer's Disease: Biology, Diagnosis and Therapeutics. Chichester Press, England, pp. 623-630.
20. Nabeshima, T., Itoh, A., 1997. Alzheimer's disease animal models induced by continuous infusion of β-amyloid protein and anti-nerve growth factor antibody. Rev. Heteroatom Chem. 16, 229-255.
21. Nabeshima, T., Nitta, A., 1994. Memory impairment and neuronal dysfunction induced by β-amyloid protein in rats. Tohoku J. Exp. Med. 174, 241-249.
22. Nabeshima, T., Ogawa, S., Ishimaru, H., Kameyama, T., Fukuta, T., Takeuchi, R., Hayashi, K., 1991. Memory impairment and morphological changes in rats induced by active fragment of anti-nerve growth factor-antibody. Biochem. Biophys. Res. Commun. 175, 215-219.
23. Nabeshima, T., Nitta, A., Hasegawa, T., 1993. Impairment of learning and memory and the accessory symptom in aged rats as senile dementia model (3): oral administration of propentofylline produces recovery of reduced NGF content in the brain of aged rats. Jpn. J. Psychopharmacol. 13, 89-95.
24. Nitta, A., Hayashi, K., Hasegawa, T., Nabeshima, T., 1993. Development of plasticity of brain function with repeated trainings and passage of time after basal forebrain lesions in rats. J. Neural Transm. 93, 37-46.
25. Nitta, A., Itoh, A., Hasegawa, T., Nabeshima, T., 1994. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170, 63-66.
26. Nitta, A., Fukuta, T., Hasegawa, T., Nabeshima, T., 1997. Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol. 73, 51-57.
27. Olton, D.S., Becker, J.T., Handeimann, G.E., 1979. Hippocampus, space, and memory. Behav. Brain Sci. 2, 313-365.
28. Paxinos, G., Watson, C., 1986. The Rat Brain in the Stereotaxic Coordinates. Academic Press, New York.
29. Shinoda, I., Furukawa, Y., Furukawa, S., 1990. Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol. 49, 1813-1816.
30. Stephens, L.R., Logan, S.D., 1986. Arginine vasopressin stimulates inositol phospholipid metabolism in rat hippocampus. J. Neurochem. 46, 649-651.
31. Strupp, B.J., 1989. Improvement of memory by a vasopressin fragment: importance of individual differences in mnemonic function. Behav. Neurosci. 103, 743-754.
32. Till, R.E., Beckwith, B.E., 1985. Sentence memory affected by vaso-pressin analog (DDAVP) in cross-over experiment. Peptides 6, 397-402.
33. Wilcock, G.K., Esiri, M.M., Bowen, D.M., Smith, C.C., 1982. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57, 407-417.
34. Yamada, K., Nitta, A., Saito, T., Hu, J., Nabeshima, T., 1995. Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid (1-40) protein. Neurosci. Lett. 201, 155-158.
35. Yamada, K., Noda, Y., Hasegawa, T., Komori, Y., Nikai, T., Sugihara, H., Nabeshima, T., 1996. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J. Pharmacol. Exp. Ther. 276, 460-466.
36. Yamada, K., Tanaka, T., Senzaki, K., Kameyama, T., Nabeshima, T., 1998. Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40). Eur. J. Pharmacol. 349, 15-22.
37. Zhou, A.W., Guo, J., Wang, H.Y., Gu, B.X., Du, Y.C., 1995. Enhance of NGF gene expression in rat brain by the memory-enhancing peptide AVP(4-8). Peptides 16, 581-586.